A Phase 1/2 Study to Investigate the Safety, Tolerabilit

Project: Research project

Description

A Phase 1/2 Study to Investigate the Safety, Tolerability and Potential Activity of IPI-504 in Relapsed ans/or Refractory Sage IIIb (with Malignant Pleural or Pericardial Effusion), or Stage IV NSCLC Patients
StatusFinished
Effective start/end date2/2/104/8/10

Funding

  • INFINITY PHARMACEUTICALS, INC.

Fingerprint

tanespimycin
Malignant Pleural Effusion
Pericardial Effusion
Safety